"Anemia, Hypochromic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Anemia characterized by a decrease in the ratio of the weight of hemoglobin to the volume of the erythrocyte, i.e., the mean corpuscular hemoglobin concentration is less than normal. The individual cells contain less hemoglobin than they could have under optimal conditions. Hypochromic anemia may be caused by iron deficiency from a low iron intake, diminished iron absorption, or excessive iron loss. It can also be caused by infections or other diseases, therapeutic drugs, lead poisoning, and other conditions. (Stedman, 25th ed; from Miale, Laboratory Medicine: Hematology, 6th ed, p393)
| Descriptor ID |
D000747
|
| MeSH Number(s) |
C15.378.071.196
|
| Concept/Terms |
Anemia, Hypochromic- Anemia, Hypochromic
- Anemias, Hypochromic
- Hypochromic Anemia
- Hypochromic Anemias
|
Below are MeSH descriptors whose meaning is more general than "Anemia, Hypochromic".
Below are MeSH descriptors whose meaning is more specific than "Anemia, Hypochromic".
This graph shows the total number of publications written about "Anemia, Hypochromic" by people in this website by year, and whether "Anemia, Hypochromic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 2 | 0 | 2 |
| 1997 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2003 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Anemia, Hypochromic" by people in Profiles.
-
Microcytic Anemia. Pediatr Rev. 2021 01; 42(1):41-43.
-
Intestinal DMT1 is critical for iron absorption in the mouse but is not required for the absorption of copper or manganese. Am J Physiol Gastrointest Liver Physiol. 2015 Oct 15; 309(8):G635-47.
-
Assessing symptom burden using the M. D. Anderson symptom inventory in patients with chemotherapy-induced anemia: results of a multicenter, open-label study (SURPASS) of patients treated with darbepoetin-alpha at a dose of 200 microg every 2 weeks. Cancer. 2007 Oct 01; 110(7):1629-40.
-
Double-blind, placebo-controlled study of quality of life, hematologic end points, and safety of weekly epoetin alfa in children with cancer receiving myelosuppressive chemotherapy. J Clin Oncol. 2006 Aug 01; 24(22):3583-9.
-
Percentage of hypochromic red blood cells is an independent risk factor for mortality in kidney transplant recipients. Am J Transplant. 2004 Dec; 4(12):2075-81.
-
Assessment of hematologic effects and fatigue in cancer patients with chemotherapy-induced anemia given darbepoetin alfa every two weeks. J Support Oncol. 2003 Jul-Aug; 1(2):131-8.
-
Fludeoxyglucose positron emission tomography in the diagnosis of giant cell arteritis. Arch Intern Med. 2001 Apr 09; 161(7):1003-7.
-
Red cell ferritin, a marker of iron deficiency in hemodialysis patients. Ren Fail. 1997 Nov; 19(6):771-80.
-
Chronic iron deficiency anemia of unknown etiology. Hosp Pract (Off Ed). 1994 Feb 15; 29(2):73, 76.
-
Atypical presentation of Crohn's disease: severe, recurrent iron deficiency anemia dependent on blood transfusions. Am J Gastroenterol. 1994 Jan; 89(1):113-5.